⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL92834 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL5379762 | 0.81 | MEN1 (0.39) | — | |
| SCHEMBL18778812 | 0.78 | LDHA (0.42) | — | |
| SCHEMBL14178232 | 0.78 | CA2 (0.38) | — | |
| SCHEMBL16652977 | 0.77 | CA1 (0.31) | — | |
| SCHEMBL19955899 | 0.76 | CA2 (0.36) | — | |
| SCHEMBL968395 | 0.76 | — | — | |
| SCHEMBL21872359 | 0.76 | CA2 (0.36) | — | |
| SCHEMBL1385036 | 0.76 | — | — | |
| SCHEMBL7739122 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765676-B2 | Calcium sensing receptor modulating compounds and pharmaceutical use thereof | LEO PHARMA A/S (DK) | 2014-07-01 | — | — | US | claimed |
| US-20120122784-A1 | NOVEL CALCIUM SENSING RECEPTOR MODULATING COMPOUNDS AND PHARMACEUTICAL USE THEREOF | LEO PHARMA A/S (DK) | 2012-05-17 | — | — | US | claimed |
| WO-2010136037-A1 | NOVEL CALCIUM SENSING RECEPTOR MODULATING COMPOUNDS AND PHARMACEUTICAL USE THEREOF | LEO PHARMA A/S (DK) | 2010-12-02 | — | — | WO | claimed |
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | claimed |
| EP-1326835-A1 | BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-07-16 | — | — | EP | claimed |
| JP-2002541145-A | — | — | 2002-12-03 | — | — | JP | claimed |
| US-20020151550-A1 | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors | NEUROGEN CORPORATION (US) | 2002-10-17 | — | — | US | claimed |
| WO-2002028835-A1 | BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-04-11 | — | — | WO | claimed |
| US-6358949-B1 | CARDIOVASCULAR AND SEXUAL DISORDERS; DIABETES, KIDNEY DISEASE, LIVER CIRRHOSIS; ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIASTHMATICS | NEUROGEN CORPORATION | 2002-03-19 | — | — | US | claimed |
| EP-1165518-A2 | BENZIMIDAZOLE AND IMIDAZOLOPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE MODULATORS OF BRADYKININ B2 (= BK-2) RECEPTORS | NEUROGEN CORPORATION (US) | 2002-01-02 | — | — | EP | claimed |
| WO-2000059886-A2 | BENZIMIDAZOLE ABD IMIDAZOLOPHYRIDINE DERIVATIES, THEIR PREPARATION AND THEIR USE AS SELECTIVE MODULATORS OF BRADYKININ B2 (=BK-2) RECEPTORS | NEUROGEN CORPORATION (US) | 2000-10-12 | — | — | WO | claimed |
| US-20140221340-A1 | CHEMOKINE RECEPTOR ACTIVITY REGULATOR | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2014-08-07 | — | — | US | disclosed |
| US-20140221340-A1 | CHEMOKINE RECEPTOR ACTIVITY REGULATOR | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2014-08-07 | — | — | US | disclosed |
| US-8765676-B2 | Calcium sensing receptor modulating compounds and pharmaceutical use thereof | LEO PHARMA A/S (DK) | 2014-07-01 | — | — | US | disclosed |
| US-20120122784-A1 | NOVEL CALCIUM SENSING RECEPTOR MODULATING COMPOUNDS AND PHARMACEUTICAL USE THEREOF | LEO PHARMA A/S (DK) | 2012-05-17 | — | — | US | disclosed |
| EP-1326835-A1 | BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-07-16 | — | — | EP | disclosed |
| US-20020151550-A1 | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors | NEUROGEN CORPORATION (US) | 2002-10-17 | — | — | US | disclosed |
| WO-2002028835-A1 | BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-04-11 | — | — | WO | disclosed |
| US-6358949-B1 | CARDIOVASCULAR AND SEXUAL DISORDERS; DIABETES, KIDNEY DISEASE, LIVER CIRRHOSIS; ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIASTHMATICS | NEUROGEN CORPORATION | 2002-03-19 | — | — | US | disclosed |
| EP-0337640-A1 | Process for producing substituted vinyl pyridines | Takeda Chemical Industries, Ltd. (JP) | 1989-10-18 | — | — | EP | disclosed |